LBO — THEDACARE MEDICAL CENTER-NEW LONDON
IRR: 17.8% | MOIC: 2.27x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
17.8%
IRR
2.27x
MOIC
$35.7M
Entry EV
$56.3M
Exit EV
$18.4M
Equity Invested
Sources & Uses
S&UTotal · $35.7M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $13.9M | 38.8% | |
| Sub Debt | $3.5M | 9.7% | |
| Equity | $18.4M | 51.5% | |
| Enterprise Value | $34.7M | 97.1% | |
| Transaction Fees | $1.0M | 2.9% | |
| Total Uses | $35.7M | 100.0% |
Interpretation
INTAt 2.27x MOIC and 17.8% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $5.4M |
| Exit Ev | $56.3M |
| Net Debt At Exit | $14.7M |
| Equity At Exit | $41.6M |
| Equity Invested | $18.4M |
| Total Value Created | $23.3M |
| Value From Growth | $19.9M |
| Value From Multiple | $1.7M |
| Value From Deleveraging | $2.7M |